Atlas Trials

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Clinical trial NCT02582697 · RECRUITING

Trial details

NCT number
NCT02582697
Sponsor
University of Sydney
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Germ Cell Tumor
Start date
2014-02-01
Primary completion
2029-12-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.